Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Tilray, Inc. operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.
  • Current market environment: positive. Prices of production are 17.7% higher compared to the last 12 months (LTM)
  • Prices of production are at 62.7% percentile over the past 5 years, adjusted for inflation
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 25.6% (LTM), projected 33.8%
  • Share price is 60.3% higher than minimum and 87.7% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-0.1x vs
    )
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (
    vs
    )

Key Financials (Download financials)

Ticker: TLRY
Share price, USD:  (-17.6%)0.5769
year average price 1.0724  


year start price 2.0100 2024-07-30

max close price 2.0300 2024-07-31

min close price 0.3600 2025-06-20

current price 0.6997 2025-07-29
Common stocks: 460 254 275

Dividend Yield:  0.0%
FCF Yield LTM / expected: 25.6% / 33.8%
EV / LTM EBITDA: -0.1x
Production prices change from LTM: 17.7%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 266
Net Debt ($m): 44
EV (Enterprise Value): 310
EBITDA LTM ($m): -2 149
EV / LTM EBITDA: -0.1x
Price to Book: 0.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2025-07-28seekingalpha.com

Tilray Brands, Inc. (TLRY) Q4 2025 Earnings Call Transcript

2025-07-28seekingalpha.com

Tilray Q4 Results Show Major Problems

2025-07-14marketbeat.com

Tilray Shares Blazing: What's Behind the 55% Rally This Month?

2025-07-07zacks.com

Here's Why Tilray Brands, Inc. (TLRY) Fell More Than Broader Market

2025-05-03fool.com

Why Tilray Stock Plummeted by 26% in April

2025-04-28seekingalpha.com

Tilray Brands Could Bounce Big

2025-04-10seekingalpha.com

Tilray: Sell Before Potential Reverse Split

2025-04-09seekingalpha.com

Tilray: Q3 Earnings Could Be The Inflection Point It Needs

2025-04-08seekingalpha.com

Tilray Brands, Inc. (TLRY) Q3 2025 Earnings Call Transcript

2025-04-08proactiveinvestors.com

Tilray shares sink after quarterly revenue falls short of estimates
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company